• head_banner_01

ʻO Tirzepatide 15 mg / vial pauka no ka inikini no ka poho kaumaha

ʻO ka wehewehe pōkole:

Ka inoa: Tirzepatide Injection Powder

Maʻemaʻe: 99%

Nui: 15mg

Wai: 3.0%

ʻAno: White Lyophilized Powder

Solubility: Kūlike

Hōʻike HPLC: Kūlike

ʻO nā Endotoxins Bacterial: emi iho ma mua o 5 EU/mg

ʻIkepili MS: 4810.6

Pōmaikaʻi: Hoʻemi kaumaha

 


Huahana Huahana

Huahana Huahana

wehewehe

ʻO Tirzepatide 15mg / Vial Lyophilized Powder no ka hoʻoheheʻe - Hoʻoponopono Weight
Inoa Huahana: Tirzepatide 15mg / Vial Powder no ka Injection
Hoʻohana: Hoʻohana nui ʻia no ka ** hoʻokele paona (Weight Loss) a me ka maʻi diabetes type 2 (T2DM)** noiʻi
ʻAi: 15mg/boule (Vial)
Maʻemaʻe: ≥99% (māka noiʻi)
ʻAno: Lyophilized Powder
Nā kūlana mālama:

Ma mua o ka hoʻomākaukau ʻana: E kau i ka friji ma 2°C~8°C, e pale i ka lā pololei
Ma hope o ka hoʻomākaukau ʻana: E kūʻai ma 2 ° C ~ 8 ° C, ʻōlelo ʻia e hoʻohana i loko o 24-48 mau hola

Nā kuhikuhi

✅ Keʻano hoʻopau:
E hoʻohana i ka ** wai maʻemaʻe no ka iniki (Wai Bacteriostatic, BW) a i ʻole 0.9% sodium chloride solution (Normal Saline, NS)** e hoʻoheheʻe.
E hoʻohuli mālie i ka ʻōmole, mai hoʻoluliluli ikaika e pale aku i ka hōʻino ʻana i ke ʻano protein

✅ ʻO ke ʻano o ka injection:
Subcutaneous injection (SC), maʻamau i hoʻokahi manawa i ka pule, pono e hoʻoponopono ʻia ka nui kikoʻī e like me ka noiʻi a i ʻole ka ʻōlelo aʻo a ke kauka.
Kahi e hoʻokomo ai: ʻōpū, ʻūhā waho a i ʻole ka lima o luna

Hoʻomalu
⚠ E ʻoluʻolu e nīnau i kekahi limahana lapaʻau ʻoihana ma mua o ka hoʻohana ʻana
⚠ E mālama i ka hana aseptic i ka wā o ka hoʻomākaukau ʻana i mea e pale aku ai i ka hoʻohaumia ʻana
⚠ Mai hoʻohana inā loaʻa ka ʻulaʻula, ka ua a me nā ʻāpana


  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou